Pharmacy Times
JANUARY 10, 2025
As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.
STAT
JANUARY 10, 2025
In an apparently unprecedented move, Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money. Most drug companies have venture funds, which they use both to make investments and to scout out potentially important scientific and technological trends. But it is unusual for a drug giant to co-manage a fund with an existing venture capital firm, or for a venture capital fund to source its capital from a
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 10, 2025
Private equity firm New Mountain Capital plans to acquire Machinify and combine its with its previous merger of The Rawlings Group, Apixios Payment Integrity business and Varis to create a powerhouse in the payment integrity market. The combined entity will have revenue of more than $500 million.
Pharmaceutical Technology
JANUARY 10, 2025
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
JANUARY 10, 2025
Drugstore chain Walgreens reported a loss of $265 million in its fiscal first quarter, which ended November 30, as it executes an ongoing turnaround strategy and continues to struggle with lower retail sales.
Drug Topics
JANUARY 10, 2025
Sarah Gray, PharmD, GAICD, known as the Nutrition Pharmacist, joined Drug Topics to discuss her experience with patients looking to begin healthier lifestyles at the start of a new year.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JANUARY 10, 2025
Researchers performed a systematic literature review of the efficacy of amitriptyline for treating patients with irritable bowel syndrome.
Fierce Healthcare
JANUARY 10, 2025
A group of UnitedHealth Group shareholders are pressuring the company to examine practices they say deny or limit patient access to care. | A group of UnitedHealth Group shareholders are pressuring the company to examine practices they say deny or limit patient access to care.
Pharmacy Times
JANUARY 10, 2025
Limited access to healthy food in redlined communities contributes to higher rates of chronic disease and reduced life expectancy.
The Checkup by Singlecare
JANUARY 10, 2025
Gabapentin is a prescription medication used to treat nerve pain and epilepsy. Although gabapentin is an anticonvulsant , its often used off-label to treat restless legs syndrome (RLS) and other nerve conditions or neuropathic pain. It can also treat postherpetic neuralgia, a type of pain that happens after having shingles. Brand names include Neurontin and Gralise.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JANUARY 10, 2025
Invikafusp alfa (STAR0602; Marengo Therapeutics Inc) is being investigated as a treatment for advanced colorectal cancer with high tumor mutational burden.
pharmaphorum
JANUARY 10, 2025
An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.
STAT
JANUARY 10, 2025
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do plan to promenade with the official mascots, catch up on our reading and hold a listening party with Mrs. Pharmalot, where the rotation will likely include this , this , this , this and this.
Pharmacy Times
JANUARY 10, 2025
Inclusion of AI improved detection and reduced instances of false-positive test results.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JANUARY 10, 2025
Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.
Drug Topics
JANUARY 10, 2025
Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM, discuss a recent study that examined how wearing a continuous glucose monitor impacts student pharmacists.
pharmaphorum
JANUARY 10, 2025
Eyeing a first commercial launch in 2027, Intellia is re-prioritising by cutting 27% of its workforce and shelving a lung disease candidate.
STAT
JANUARY 10, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Ready for JPM? We’ll be on the ground and covering it in-depth next week. Please note: This newsletter will be dropping into your inbox in the afternoon instead of in the morning.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 10, 2025
The report includes four policy briefs on the top issues affecting kids in the area, including resiliency, vaccinations, the child welfare system and transition to adulthood. Cross-sector workgroups in each area met during a roundtable in November 2023.
Pharmafile
JANUARY 10, 2025
Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for its novel contractile agents. The round was co-led by Novo Holdings, Pureos Bioventures and Sound Bioventures. AnaCardios AC01 is a calcium sensitising inotrope, selective oral ghrelin receptor (GHSR1a) agonist in development to improve contractility in […] The post AnaCardio raises $19m in funding round for heart failure candidate appeared first on Phar
Fierce Healthcare
JANUARY 10, 2025
Health tech company Innovaccer secured a $275 million series F funding round to invest in artificial intelligence with the goal to become a one stop shop for healthcare AI solutions.
Pharmacy Times
JANUARY 10, 2025
Funding supports critical community pharmacy advocacy efforts to elevate and sustain the pharmacy profession.
Fierce Healthcare
JANUARY 10, 2025
While there was less money in early-stage financing and a surge in publicly-disclosed down rounds, investment in venture capital-backed healthcare companies ticked up in 2024, according t | Total investment in health tech companies grew by 17% in 2024. AI companies and women's health companies attracted investor interest.
Pharmacy Times
JANUARY 10, 2025
ALG-801 could present new opportunities to improve treatment and management of patients with pulmonary arterial hypertension, a life-threatening condition.
Fierce Healthcare
JANUARY 10, 2025
You may have missed this month. Massachusetts ordered UnitedHealth companies to pay $165 million for tricking customers to buy supplemental insurance, Scripps Health is no longer in market for Anthem Blue Cross members and Molina Healthcare is addressing depressive disorders with a new home health partnership.
Pharmacy Times
JANUARY 10, 2025
The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
PharmaVoice
JANUARY 10, 2025
Coming changes that could impact pharma from drug development to launch.
Pharmaceutical Technology
JANUARY 10, 2025
GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimers disease in 2033.
Pharmacy Times
JANUARY 10, 2025
In a phase 2 trial (NCT05400226), abenacianine helps surgeons visualize tumors in lung during surgery and is safe and well-tolerated in patients.
Pharmaceutical Technology
JANUARY 10, 2025
Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising CLYM116.
Fierce Healthcare
JANUARY 10, 2025
CMS is recommending a 2.23% payment increase from the federal government to MA plans. Payers will likely be much happier at this year's advance notice than the prior year's rate cut.
Pharmaceutical Technology
JANUARY 10, 2025
Coave has raised 32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
pharmaphorum
JANUARY 10, 2025
A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.
Expert insights. Personalized for you.
139 
Let's personalize your content